Mark Ragosa, CHIEF FINANCIAL OFFICER at Kiniksa Pharmaceuticals International, plc (KNSA), sold 37,778 shares at $32.89 ($1.2M) on 2025-08-04, disclosed to the SEC on 2025-08-06.
Scheduled sale ($1.2M) by CHIEF FINANCIAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.89 | 18,889 | $621K | 50.0% |
| 2 | $32.89 | 18,889 | $621K | 50.0% |
| Total | $32.89 avg | 37,778 | $1.2M | 100% |
| Filing → |
| KNSA | SELL | 2026-01-09 | $503K | — | Filing → |
| KNSA | SELL | 2025-12-10 | $3.6M | — | Filing → |
| KNSA | SELL | 2025-11-14 | $815K | — | Filing → |